Mark DeLong - Jan 21, 2022 Form 4/A - Amendment Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Senior Vice President
Signature: /s/ David Watson, attorney-in-fact
Stock symbol: APLS
Transactions as of: Jan 21, 2022
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 2/7/2022, 07:06 PM
Date Of Original Report: Jan 25, 2022
Previous filing: Oct 27, 2021
Next filing: Feb 1, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Award	$0	+13.9K	+134.14%	$0.00	24.3K	Jan 21, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (right to buy)	Award	$0	+19.7K		$0.00	19.7K	Jan 21, 2022	Common Stock	19.7K	$35.46	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This represents a restricted stock unit grant made on January 21, 2022 that vests 25% annually in equal installments over four years from the date of grant, subject to continued service.
F2	On January 23, 2021, the reporting person filed a Form 4 that inadvertently reported that the reporting person was granted a restricted stock unit of 10,952 shares. This amendment is being filed solely to correct such number of shares to 13,913.
F3	This represents a non-qualified stock option grant made on January 21, 2022 that vests over a four year period with 25% vesting one year from grant date and the remaining 75% vesting in equal monthly installments thereafter through the fourth anniversary of the grant date, subject to continued service.
F4	On January 23, 2021, the reporting person filed a Form 4 that inadvertently reported that the reporting person was granted a non-qualified stock option grant of 15,024 shares. This is amendment is being filed solely to correct such number of shares to 19,735.